openPR Logo
Press release

Anti-Epileptic Drugs for Pediatrics Market Projected to Witness Vigorous Expansion in Forecast years 2026

10-30-2020 03:59 PM CET | Health & Medicine

Press release from: coherenet market insights

Anti-Epileptic Drugs for Pediatrics Market

Anti-Epileptic Drugs for Pediatrics Market

Anti-epileptic drugs for pediatric treatment are expected to experience visible shifts in terms of demand and adoption owing to factors such as rise in global prevalence of epilepsy, increasing healthcare spending and emergence of efficacious anti-epileptic drugs. Furthermore, co-morbidities associated with epilepsy such as depression and anxiety are on the rise and major players are investing in research and awareness programs for reduction of these co-morbidities along with epilepsy.

For instance, Sanofi, S.A. invests in awareness programs in regions such as Latin America, Africa, and Asia Pacific. The company offers products with price adjustments in these regions to increase the access to treatments. Moreover, product launches and approvals such as the Vimpat drug approvals in Europe and Japan for the treatment of partial onset seizures for UCB Pharma in 2016, are aiding the market growth.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/823

Global Anti-epileptic Drugs for Pediatrics Market Competitive Landscape

Key players operating in the global Anti-epileptic Drugs for Pediatrics market include Mylan N.V., Cephalon, Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals, Novartis AG, Pfizer, Inc., Sanofi S.A., UCB Pharma Limited, Sunovion Pharmaceuticals Limited, Valeant Pharmaceuticals International, Inc., Zynerba, Zogenix, and Insys Therapeutics.

Market Dynamics

Rising incidence of epilepsy is expected to drive the anti-epileptic drugs for pediatrics market growth over the forecast period. For instance, according to the American Academy of Pediatrics 2016, epilepsy is the most common childhood brain disorder in the U.S., and nearly 3 million Americans have this condition (450,000 of which are under the age of 17).

Major players are focusing on providing viable treatment options for patients suffering from refractory epilepsy or drug resistant epilepsy. The add-on or adjunctive therapies offer significant positive results with relatively less side effects. This, in turn, is expected to boost the market growth for anti-epileptic drugs. Some notable drugs in the pipeline such as Lyrica (Pregabalin), are showing potential therapeutic effects with fewer drug interactions, improved side effect profiles, and enhanced overall safety. These factors are expected to favour the market growth since most of the older treatments such as carbamazepine, valproate, and phenytoin, although effective, have very poor safety profiles and are not well-tolerated by pediatric patients.

Newer drug therapies with symptom specific indications are expected to boost market growth

Epilepsy is a highly prevalent disorder, and an estimated 50 million people worldwide are suffering from epilepsy, out of which almost 80% live in emerging economies as per the World Health Organization (WHO) 2019. According to the American Academy of Pediatrics, as of April 2017, epilepsy was estimated to affect 0.5% to 1% of children globally and is the most prevalent chronic condition of the central nervous system among children. According to Epilepsy Foundation, each year, around 150,000 new cases of epilepsy are reported in the U.S. and the rate of occurrence is high among young children and geriatric population. Furthermore, in 2015, the Society of Neuroscience stated that epilepsy affected around 10.5 million children worldwide, and the type and severity of the disorder varies significantly.

The incidence and prevalence of epilepsy in children appears to be lower in developed economies and highest in rural areas of emerging economies. This is mainly attributed to the presence of FDA-approved anti-epileptic drugs in developed economies and vast distribution channels ensuring higher accessibility to treatments. Scientific and technological advancements have led to the introduction of several medications in the past decade, which are used in combination in a personalized way by physicians for the treatment of pediatrics. Drugs approved by the U.S. Food & Drug Administration (FDA) include Phenytoin (Dilantin), Carbamazepine (Carbatrol), Divalproex Sodium (Depakote), and Ethosuximide (Zarontin).

Global Anti-epileptic Drugs for Pediatrics Market - Restraints

However, lack of awareness regarding epilepsy and non-availability of medical facilities in poor and developing countries are some of the factors that are expected to hinder growth of the anti-epileptic drugs for pediatrics market.

Browse Research Report At: https://www.coherentmarketinsights.com/market-insight/anti-epileptic-drugs-for-pediatrics-market-823

Key features of the study:

This report provides in-depth analysis of the global anti-epileptic drugs for pediatrics market, market size (US$ Mn), and compound annual growth rate (CAGR %) during the forecast period: 2019 – 2027, considering 2018 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players operating in this market
It profiles key players in the global anti-epileptic drugs for pediatrics market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
Key players covered as a part of this study include Mylan N.V., Cephalon, Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals, Novartis AG, Pfizer, Inc., Sanofi S.A., UCB Pharma Limited, Sunovion Pharmaceuticals Limited, Valeant Pharmaceuticals International, Inc., Zynerba, Zogenix and Insys Therapeutics.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global anti-epileptic drugs for pediatrics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global anti-epileptic drugs for pediatrics market, research and consulting firms, new entrants, and financial analysts

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Epileptic Drugs for Pediatrics Market Projected to Witness Vigorous Expansion in Forecast years 2026 here

News-ID: 2177420 • Views: 546

More Releases from coherenet market insights

Global Oncology Drugs Market Application 2020 - Industry Overview, Global Trends …
Global Oncology Drugs - Competitive Analysis Market Report, Sales and Consumption Status and Prospects Professional Research, the report classifies the Global Global Oncology Drugs - Competitive Analysis Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Oncology drugs and medications have become a blooming business for players in the pharmaceutical industry. Major pharmaceutical companies are focused on manufacturing and
Diabetic Neuropathy Market Sales Projection, Growth Estimation, Size Analysis, K …
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population
Augmented Reality in Healthcare Market with Future Prospects, Industry Capacity, …
Augmented reality is gaining prominence among medical personnel for various applications ranging from surgical preparation assessment to minimally-invasive surgery and rehabilitation. Various healthcare IT-enabled companies are venturing into the augmented reality in healthcare market to capitalize on the high growth opportunities on offer. The million dollar market is witnessing technology disruption and is expected to grow at a robust double digit CAGR during 2016–2024. Augmented reality is finding wide application
Medical Disposables Market with Covid-19 Effect Analysis | likewise Industry is …
This is often the latest report, covering the present COVID-19 impact on the Medical Disposables Market. The Medical Disposables market research report classifies the market into different segments to better analyze the Medical Disposables market. The Medical Disposables market report delivers accurate information. An expected growth trend to be followed by the Medical Disposables market is also included in the report. Medical Disposables Market Report includes the product contributions, revenue generated,

All 5 Releases


More Releases for Pediatrics

International Conference on Pediatrics and Pediatrics Health
Medical Conferences cordially invite you to attend the esteemed conference on “Pediatrics & Pediatrics Health” which will be held during October 07-08, 2019 in Rome, Italy. The sessions and topics of this event will be revolving around the theme Advanced Concepts and Frameworks in Child Health & Adolescent Treatments. Pediatrics 2019 will be a unique and international blend of big and small companies, leading universities, research institutions and hospitals. This event
WORLD CONGRESS ON OBSTETRICS, GYNECOLOGY & PEDIATRICS 2019
We would be glad to announce World Congress on Obstetrics, Gynecology & Pediatrics 2019 is scheduled on July 29-30, 2019 at Holiday Inn, Atrium, Singapore organized by Larix International. Pediatrics 2019 conference will focus on the latest and exciting innovations in all the areas of Obstetrics, Gynaecology and Paediatric research. This year’s annual congress highlights the theme, Best Practices in Women and Child Care which reflects the innovative progress in Paediatric
WORLD CONGRESS ON OBSTETRICS, GYNECOLOGY & PEDIATRICS 2019
Theme: “Best Practices in Women and Child care” OGP- 2019 conference will focus on the latest and exciting innovations in all the areas of Obstetrics, Gynaecology and Paediatric research. This year’s annual congress highlights the theme, Best Practices in Women and Child Care which reflects the innovative progress in Paediatric and women disease research. We are excited to present our 2019 program which will be both inclusive and diverse and bring
28th International Conference on Pediatrics Health
Pediatrics Health 2019 - We welcome all the Pediatricians throughout the world to attend 28th International Conference on Pediatrics Health which will be held on August 12-14, 2019 at Rome, Italy. Pediatrics Health 2019 is an extraordinary event which brings together a unique and international mix of large and medium companies, leading universities, research institutions and hospitals in the field of Pediatrics to the historical city of Rome,
26th European Pediatrics Congress
ConferenceSeries Ltd invites you to attend the 26th European Pediatrics Conference, to be held October 22 – 23, 2018 in Amsterdam , Netherlands .We sincerely welcome all the eminent researchers, students and delegates to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future revolutions in the field of Pediatrics. Euro Pediatrics 2018 will be sorted out around the theme “Enlightening The Advancements
18th International Conference on Pediatrics Health
18th International Conference on Pediatrics Health August 06 -07, 2018 Madrid, Spain. ConferenceSeries LLC welcomes all the Pediatricians throughout the world to attend “18th International Conference on Pediatrics Health” which will be held during August 06 -07, 2018 Madrid, Spain. Pediatrics Health 2018 is an extraordinary event which brings together a unique and international mix of large and medium companies, leading universities, research institutions and hospitals in the